About Watran Pharmaceuticals
Watran Pharmaceuticals is a Healthcare company. Pharmaceutical manufacturing, franchise services, and third-party production in India. Its Indian entity Watran Pharmaceuticals Private Limited reported revenue of ₹8.42 Cr. Watran Pharmaceuticals offers products and services including Pharmaceutical Tablets and PCD Pharma Franchise. Its focus areas include Pharmaceuticals, Drug Manufacturing, Franchise and Manufacturing Services and Distribution.
Company details
Watran Pharmaceuticals Pvt. Ltd. is recognized as a certified pharmaceutical entity in India, dealing in a broad array of products such as tablets, syrups, capsules, and injections that are produced using modern infrastructure near Kala Amb, Sirmour. Quality is ensured through adherence to ISO, WHO, GMP, and GLP standards, with examinations conducted for criteria like shelf life and effectiveness. Services including PCD Pharma Franchise and Third Party Manufacturing are offered, enabling distribution and contract production across the country to support healthcare needs.
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Legal Name Watran Pharmaceuticals Pvt. Ltd
- Date of Incorporation 02 May, 2019
- Jurisdiction Ambala, Haryana, India
- Indian entity revenue₹8.42 Cr
FY 2025 · +24% YoY
- Indian entity net profit₹10.9 Lakh
FY 2025 · 1% margin
- Indian entity EBITDA₹42.3 Lakh
FY 2025 · 5% margin
Associated legal entities of Watran Pharmaceuticals
Watran Pharmaceuticals operates through Watran Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Watran Pharmaceuticals Private Limited CIN U24304HR2019PTC080095 | Active | 02 May 2019 | Ambala, Haryana | ₹8.4 Cr | 3 | View details |
Products & Services of Watran Pharmaceuticals
Watran Pharmaceuticals offers a comprehensive portfolio of products and services, including Pharmaceutical Tablets and PCD Pharma Franchise.
Pharmaceutical tablets are manufactured and supplied for various health needs, ensuring accurate composition and effectiveness
PCD Pharma Franchise services are provided for distribution and marketing of pharmaceutical products across India
Board of directors of Watran Pharmaceuticals Private Limited (Watran Pharmaceuticals)
Watran Pharmaceuticals Private Limited is the primary company behind Watran Pharmaceuticals. The board of Watran Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Sachin Kumar, appointed in 2023. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sachin Kumar DIN 10304242 | Director | 19 Oct 2023 | 3 yrs | Watran Pharmaceuticals Private Limited |
| Reena Rani DIN 11135011 | Director | 15 Nov 2025 | 11 mo | Watran Pharmaceuticals Private Limited |
| Manjeet Kaur DIN 11223221 | Director | 15 Nov 2025 | 11 mo | Watran Pharmaceuticals Private Limited |
Financials of Watran Pharmaceuticals
Figures of Watran Pharmaceuticals Private Limited, the primary company behind Watran Pharmaceuticals, for FY 2025. Revenue was ₹8.42 Cr (+24% year on year). Net profit was ₹10.9 Lakh (1% margin). EBITDA was ₹42.3 Lakh (5% margin). Revenue has grown at a compounded annual rate of +7% over three years and +54% over five years.
- ₹8.42 CrRevenue · FY 2025 · +24% YoY
- ₹10.9 LakhNet profit · 1% margin
- ₹42.3 LakhEBITDA · 5% margin
- ₹6 LakhPaid-up capital
- +7%Revenue CAGR, 3 years
- +54%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Watran Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Watran Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Watran Pharmaceuticals
The primary company behind Watran Pharmaceuticals, Watran Pharmaceuticals Private Limited, reported revenue of ₹8.42 Cr for FY 2025, up 24% year on year.
Watran Pharmaceuticals Pvt. Ltd. is recognized as a certified pharmaceutical entity in India, dealing in a broad array of products such as tablets, syrups, capsules, and injections that are produced using modern infrastructure near Kala Amb, Sirmour. Quality is ensured through adherence to ISO, WHO, GMP, and GLP standards, with examinations conducted for criteria like shelf life and effectiveness. Services including PCD Pharma Franchise and Third Party Manufacturing are offered, enabling distribution and contract production across the country to support healthcare needs.
Watran Pharmaceuticals offers Pharmaceutical Tablets and PCD Pharma Franchise.
Watran Pharmaceuticals operates through Watran Pharmaceuticals Private Limited.
The legal entities of Watran Pharmaceuticals currently have 3 directors, including Sachin Kumar, Reena Rani, Manjeet Kaur.